In 2013, we established Novadip Biosciences to develop a new class of regenerative tissue products that will accelerate healing in patients with limited or no effective treatment options. Over the ensuing 10 years we worked to raise capital to support efforts to...
“A Decade of Progress, An Exciting Future in Regenerative Medicine”
read more